Catheter‑directed thrombolytic therapy combined with angioplasty for hepatic vein obstruction in Budd‑Chiari syndrome complicated by thrombosis

Zhang,Qingqiao; Xu,Hao; Zu,Maoheng; Gu,Yuming; Wei,Ning; Wang,Wenliang; Gao,Zhikang; Shen,Bin

doi:10.3892/etm.2013.1239

Catheter‑directed thrombolytic therapy combined with angioplasty for hepatic vein obstruction in Budd‑Chiari syndrome complicated by thrombosis

Authors:
- Qingqiao Zhang
- Hao Xu
- Maoheng Zu
- Yuming Gu
- Ning Wei
- Wenliang Wang
- Zhikang Gao
- Bin Shen
View Affiliations

Affiliations: Department of Interventional Radiology, The Affiliated Hospital of Xuzhou Medical College, Xuzhou, Jiangsu 221006, P.R. China
Published online on: July 30, 2013 https://doi.org/10.3892/etm.2013.1239
Pages: 1015-1021

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of this study was to assess the efficacy and safety of catheter‑directed thrombolysis combined with angioplasty in the treatment of hepatic vein obstruction in Budd‑Chiari syndrome (BCS) complicated by thrombosis. In 14 cases of BCS, the patients with hepatic vein obstruction complicated by thrombosis who underwent catheter‑directed urokinase thrombolysis, balloon dilatation and/or stent placement were followed up with an ultrasound examination of the liver. Among the 13 cases of successful treatment, one hepatic vein was recanalized in 12 patients (right hepatic vein, seven cases; left hepatic vein, three cases; middle hepatic vein, one case and accessory hepatic vein, one case) and two hepatic veins (right and left) were recanalized in one patient without serious complications, such as bleeding and pulmonary embolism. There was one patient in whom the treatment was unsuccessful. During an average follow‑up period of 24.8±19.6 months, hepatic vein restenosis was observed in one patient in the sixth month after opperation; however, a successful result was obtained following a second balloon dilatation. The remaining 12 patients did not demonstrate any recurrence of restenosis or thrombosis. Catheter‑directed thrombolysis combined with angioplasty was observed to be an effective and safe method for the treatment of hepatic vein obstruction in BCS complicated by thrombosis.

View Figures

View References

1.	Darwish Murad S, Plessier A, Hernandez-Guerra M, et al: EN-Vie (European Network for Vascular Disorders of the Liver): Etiology, management, and outcome of the Budd-Chiari syndrome. Ann Intern Med. 151:167–175. 2009.PubMed/NCBI
2.	Dacha S, Devidi M and Osmundson E: Budd-Chiari syndrome in a patient with ulcerative colitis and no inherited coagulopathy. World J Hepatol. 3:164–169. 2011.PubMed/NCBI
3.	Reza F, Naser DE, Hossein G and Mehrdad Z: Combination of thrombolytic therapy and angioplastic stent insertion in a patient with Budd-Chiari syndrome. World J Gastroenterol. 13:3767–3769. 2007.PubMed/NCBI
4.	Valla DC: Primary Budd-Chiari syndrome. J Hepatol. 50:195–203. 2009. View Article : Google Scholar : PubMed/NCBI
5.	Cura M, Haskal Z and Lopera J: Diagnostic and interventional radiology for Budd-Chiari syndrome. Radiographics. 29:669–681. 2009. View Article : Google Scholar : PubMed/NCBI
6.	Molmenti EP, Segev DL, Arepally A, et al: The utility of TIPS in the management of Budd-Chiari syndrome. Ann Surg. 241:978–983. 2005. View Article : Google Scholar : PubMed/NCBI
7.	Mentha G, Giostra E, Majno PE, et al: Liver transplantation for Budd-Chiari syndrome: A European study on 248 patients from 51 centres. J Hepatol. 44:520–528. 2006. View Article : Google Scholar : PubMed/NCBI
8.	Li T, Zhang WW, Bai W, Zhai S and Pang Z: Warfarin anticoagulation before angioplasty relieves thrombus burden in Budd-Chiari syndrome caused by inferior vena cava anatomic obstruction. J Vasc Surg. 52:1242–1245. 2010. View Article : Google Scholar : PubMed/NCBI
9.	Keshava SN, Moses V and Surendrababu NR: Cannula-assisted and transabdominal ultrasound-guided hepatic venous recanalization in Budd Chiari syndrome: a novel technique to avoid percutaneous transabdominal access. Cardiovasc Intervent Radiol. 32:1257–1259. 2009. View Article : Google Scholar
10.	Li T, Zhai S, Pang Z, et al: Feasibility and midterm outcomes of percutaneous transhepatic balloon angioplasty for symptomatic Budd-Chiari syndrome secondary to hepatic venous obstruction. J Vasc Surg. 50:1079–1084. 2009. View Article : Google Scholar : PubMed/NCBI
11.	Carnevale FC, Santos AC, Tannuri U and Cerri GG: Hepatic veins and inferior vena cava thrombosis in a child treated by transjugular intrahepatic portosystemic shunt. Cardiovasc Intervent Radiol. 33:627–630. 2010. View Article : Google Scholar : PubMed/NCBI
12.	Iwasaki T, Kawai H, Oseki K, et al: Japanese case of Budd-Chiari syndrome due to hepatic vein thrombosis successfully treated with liver transplantation. Hepatol Res. 42:213–218. 2012. View Article : Google Scholar : PubMed/NCBI
13.	Clark PJ, Slaughter RE and Radford DJ: Systemic thrombolysis for acute, severe Budd-Chiari syndrome. J Thromb Thrombolysis. 34:410–415. 2012. View Article : Google Scholar
14.	Soyama A, Eguchi S, Yanaga K, Takatsuki M, Hidaka M and Kanematsu T: Living donor liver transplantation with extensive caval thrombectomy for acute-on-chronic Budd-Chiari syndrome. Surg Today. 41:1026–1028. 2011. View Article : Google Scholar : PubMed/NCBI
15.	Ding PX, Li YD, Han XW and Wu G: Agitation thrombolysis for fresh iatrogenic IVC thrombosis in patients with Budd-Chiari syndrome. J Vasc Surg. 52:782–784. 2010. View Article : Google Scholar : PubMed/NCBI
16.	Moug SJ, Craig SR, Roditi G and Horgan PG: Images of interest. Hepatobiliary and pancreatic: extensive thrombosis in Budd-Chiari syndrome. J Gastroenterol Hepatol. 20:13022005. View Article : Google Scholar : PubMed/NCBI
17.	Kuo GP, Brodsky RA and Kim HS: Catheter-directed thrombolysis and thrombectomy for the Budd-Chiari syndrome in paroxysmal nocturnal hemoglobinuria in three patients. J Vasc Interv Radiol. 17:383–387. 2006. View Article : Google Scholar : PubMed/NCBI
18.	Sharma S, Texeira A, Texeira P, Elias E, Wilde J and Olliff SP: Pharmacological thrombolysis in Budd-Chiari syndrome: a single centre experience and review of the literature. J Hepatol. 40:172–180. 2004. View Article : Google Scholar : PubMed/NCBI
19.	Enden T, Haig Y, Kløw NE, et al CaVenT Study Group: Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial. Lancet. 379:31–38. 2012. View Article : Google Scholar
20.	Manninen H, Juutilainen A, Kaukanen E and Lehto S: Catheter-directed thrombolysis of proximal lower extremity deep vein thrombosis: a prospective trial with venographic and clinical follow-up. Eur J Radiol. 81:1197–1202. 2012. View Article : Google Scholar : PubMed/NCBI
21.	Ding PX, Li YD, Han XW, Wu G, Shui SF and Wang YL: Treatment of Budd-Chiari syndrome with urokinase following predilation in patients with old inferior vena cava thrombosis. Radiol Med. 116:56–60. 2011. View Article : Google Scholar : PubMed/NCBI